Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von StockNews.com 

Tonix Pharma. Holding Corp. diskutieren

Tonix Pharmaceuticals Holding Corp.

WKN: A3EDH2 / Symbol: TNXP / Name: Tonix Pharmaceuticals / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

2,82 €
-

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for TNXP provided by MarketBeat

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for TNXP provided by MarketBeat

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for TNXP provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,00 %
Kursziel 7,29
Veränderung
Endet am 01.08.24

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) had its price target lowered by analysts at Alliance Global Partners from $18.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for TNXP provided by MarketBeat

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for TNXP provided by MarketBeat

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for TNXP provided by MarketBeat

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for TNXP provided by MarketBeat

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for TNXP provided by MarketBeat

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for TNXP provided by MarketBeat

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for TNXP provided by MarketBeat

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for TNXP provided by MarketBeat

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for TNXP provided by MarketBeat

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for TNXP provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 2,77
Veränderung
Endet am 28.02.25

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at Dawson James. They set a "buy" rating and a $3.00 price target on the stock.
Ratings data for TNXP provided by MarketBeat

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for TNXP provided by MarketBeat

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for TNXP provided by MarketBeat

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for TNXP provided by MarketBeat

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for TNXP provided by MarketBeat

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for TNXP provided by MarketBeat